Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Nael

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Pediatric Blood & Cancer|November 6, 2024
Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of NeuroblastomaSerena Y Tan, Mark G Evans, Raya Saab, et al.
Scientific Data|July 11, 2024
Histopathology imaging and clinical data including remission status in pediatric inflammatory bowel diseaseChloe Martin-King, Ali Nael, Louis Ehwerhemuepha, et al.
Pediatric Blood & Cancer|July 22, 2025
Emergence and Implications of DNMT3A Mutations in Pediatric AML Post-HSCT: A Case Report and Literature ReviewAarushi Madan, Amitesh Anerao, Danielle Mucker, et al.
Oncogenesis|September 6, 2022
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppressionStephanie C Wu, Ahhyun Kim, Yijun Gu, et al.
Gastro Hep Advances|March 30, 2026
Pediatric Inflammatory Bowel Disease Tissue Classification From Pathology Slide Images: Detecting Phenotypes Using Computer VisionChloe Martin-King, Ali Nael, Louis Ehwerhemuepha, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Cancer Discovery|March 28, 2013
De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patientsDavid Akhavan, Alexandra L Pourzia, Alex A Nourian, et al.
Cancer Discovery|December 7, 2011
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistanceKazuhiro Tanaka, Ivan Babic, David Nathanson, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Pediatric Blood & Cancer|November 6, 2024
Aggressive Pediatric Primitive Round Cell Tumors with MN1::ZNF341 Fusion: A Mimic of NeuroblastomaSerena Y Tan, Mark G Evans, Raya Saab, et al.
Scientific Data|July 11, 2024
Histopathology imaging and clinical data including remission status in pediatric inflammatory bowel diseaseChloe Martin-King, Ali Nael, Louis Ehwerhemuepha, et al.
Pediatric Blood & Cancer|July 22, 2025
Emergence and Implications of DNMT3A Mutations in Pediatric AML Post-HSCT: A Case Report and Literature ReviewAarushi Madan, Amitesh Anerao, Danielle Mucker, et al.
Oncogenesis|September 6, 2022
UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppressionStephanie C Wu, Ahhyun Kim, Yijun Gu, et al.
Gastro Hep Advances|March 30, 2026
Pediatric Inflammatory Bowel Disease Tissue Classification From Pathology Slide Images: Detecting Phenotypes Using Computer VisionChloe Martin-King, Ali Nael, Louis Ehwerhemuepha, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 27, 2013
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesAkio Iwanami, Beatrice Gini, Ciro Zanca, et al.
Cancer Discovery|March 28, 2013
De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patientsDavid Akhavan, Alexandra L Pourzia, Alex A Nourian, et al.
Cancer Discovery|December 7, 2011
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistanceKazuhiro Tanaka, Ivan Babic, David Nathanson, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
Pageof 4